Details for Patent: 5,643,602
✉ Email this page to a colleague
Summary for Patent: 5,643,602
| Title: | Oral composition for the treatment of inflammatory bowel disease |
| Abstract: | An oral pharmaceutical composition is described for targeted slow release in the treatment of inflammatory bowel diseases. Also described are pharmaceutical compositions for peroral treatment targeted to different areas of the intestinal tract afflicted by ulcerative colitis and certain aspects of Crohn's disease. |
| Inventor(s): | Ulmius; Jan (Lund, SE) |
| Assignee: | Astra Aktiebolag (Sodertalje, SE) |
| Application Number: | 08/240,078 |
|
Patent Claim Types: see list of patent claims | Use; Formulation; Dosage form; Composition; Process; |
Drugs Protected by US Patent 5,643,602
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 5,643,602
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Sweden | 8903914 | Nov 22, 1989 |
International Family Members for US Patent 5,643,602
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 125445 | ⤷ Sign Up | |||
| Australia | 643021 | ⤷ Sign Up | |||
| Australia | 7786491 | ⤷ Sign Up | |||
| Canada | 2071518 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
